Frontier Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-382,648
| Closed | -$3.67M | – | 270 |
|
|
2022
Q3 | $3.67M | Buy |
382,648
+65,259
| +21% | +$625K | 0.04% | 248 |
|
|
2022
Q2 | $3.5M | Sell |
317,389
-111,869
| -26% | -$1.24M | 0.04% | 257 |
|
|
2022
Q1 | $7.15M | Sell |
429,258
-108,039
| -20% | -$1.8M | 0.06% | 232 |
|
|
2021
Q4 | $10.3M | Sell |
537,297
-139,645
| -21% | -$2.67M | 0.08% | 221 |
|
|
2021
Q3 | $16.7M | Sell |
676,942
-337,871
| -33% | -$8.33M | 0.13% | 186 |
|
|
2021
Q2 | $26.4M | Buy |
+1,014,813
| New | +$26.4M | 0.19% | 165 |
|